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Evidence that the hippocampus plays an impor-
tant role in advanced neuro-cognitive functions 
(NCF), including the formation of new memories, 
has accumulated since the 1950s [1]. Reports de-
scribing bilateral lesions in the hippocampus that 
developed clinically detectable neurological im-
pairments suggest that bilateral damage of this 
structure have negative effects [2–3]. Recently, the 
randomized NRG-CC001 study [4] provided ad-
ditional evidence that this structure is related to 
the memory functions of the brain. The authors 
found that in the setting of whole brain irradiation 
(WBRT) with memantine, lowering the bilateral 
hippocampal radiation dose preserved NCF and 
patient-reported symptoms. Importantly, relapses 
in the hippocampus avoidance (HA) region did not 
increase — occurring in 11 of 257 patients in the 
HA-WBRT plus memantine arm versus 16 of 261 
in the WBRT plus memantine arm.
In both scenarios, bilateral hippocampus alter-
ation (damage or protection) resulted in detect-
able effect on NCF (impairment or preservation, 
respectively). An intriguing subsequent question 
that arises is if the integrity of both hippocampi 
is a necessary condition for normal — or partially 
normal — NCF. 
The implications of this question for the treat-
ment of brain metastases with irradiation are nu-
merous. If the hippocampus works as a serial organ 
(similar to spinal cord), bilateral hippocampal spar-
ing would be necessary to preserve function. On the 
other hand, if the hippocampus behaves as a parallel 
organ (similar to the lung or the motor cortex of the 
brain), the avoidance of one side could result in at 
least partial neuro-cognitive benefit. The latter sce-
nario would expand the indications for hippocam-
pus avoidance because it would include patients with 
unilateral hippocampus metastasis that are generally 
not considered candidates for hippocampal preser-
vation. In the third possibility, in which only one 
specific side is responsible for the function based on 
dominance [5, 6] (e.g. the Broca’s area responsible 
for the speech production), the hippocampal spar-
ing could be unilateral instead of bilateral. In order 
to generate clinical data to help answer this ques-
tion, it is important to routinely document dose to 
each hippocampi — including incidental dose from 
focal treatments [7] — and to determine dominant 
hemisphere for each particular patient.
Unilateral avoidance is technically feasible with 
modern radiotherapy modalities [8–9]. As an illustra-
tive example, Figure 1A–D presents WBRT plans with 
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and without hippocampus sparing for a 62 years-old 
female with multiple brain metastases (eight) from 
high-grade serous carcinoma of the ovary. After re-
viewing the thin slice MRI (1 mm–1 mm), one lesion 
was close to the right hippocampus, but no lesions 
were near the left hippocampus. If WBRT is indicated, 
the lesion near the right hippocampus would need to 
be included. However, could the left hippocampus be 
avoided? Sparing of the left side could potentially pre-
serve NCF if the hippocampus is considered a parallel 
organ or if the left side is dominant.
The exact working mechanism of the hippocam-
pus is an intriguing and motivating area of transla-
tional research. Further investigation is necessary 
in determining the impacts of radiation on this 
bilateral organ, and whether patients with unilat-
eral involvement of the hippocampus may be con-
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Figure 1. Axial and coronal views of 3d conformal WBrt plan without hippocampus sparing (A, B) and volumetric modulated 
arc therapy (VMAt) plan with unilateral hippocampus sparing (C, D). red: 30 Gy isodose. dark blue: 15 Gy isodose. Cyan: right 
temporal lobe metastasis. Yellow: right hippocampus. White: right hippocampus + 5 mm. light green: left hippocampus.  
dark Green: left hippocampus + 5mm. left hippocampus d100% 8.5 Gy (target ≤ 9 Gy) and dmax 14.4 Gy (target ≤ 16 Gy)
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